•
Investing in Iterative Scopes
Talks about Venture Capital, Healthcare and personalized medicine
NL
Nan Li
Managing Partner at Dimension
NL
Nan Li
Managing Partner at Dimension
San Francisco, California
Overview
Nan Li is the Founder and Managing Partner at Dimension, a venture capital firm based in San Francisco. With a background in private equity and corporate development, Nan has successfully invested in a variety of startups, including n8n and Visor, focusing on sectors like DeepTech, Robotics, BioTech, and AI.
Noteworthy highlights of Nan's career include founding Dimension and making strategic investments in innovative companies, demonstrating expertise in venture capital, due diligence, and entrepreneurship. His role involves managing a diverse portfolio of investments and fostering strategic partnerships within the San Francisco Bay Area startup ecosystem.
Work Experience
Founder & Managing Partner
2022 - Current
Dimension Capital is a venture capital firm that prefers to invest in various industries.
Investor, Board Director
2021
Computer vision driven endoscopy for GI disease
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Investor, Board Observer
2020
Cell-free manufacturing platform for biologics
Investor, Board Observer
2020
Computational chemistry platform leveraging DNA-encoded libraries
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Raised $37,200,000.00 from Menlo Ventures, Air Street Capital, Obvious Ventures, Lux Capital, Expeditions Fund, Catalio Capital Management, Mei Z. and Khosla Ventures.
Investor
2019
Open source API platform for everything
Investor, Board Director
2019
Computational protein engineering for antibodies and bi-specifics
Investor, Board Director
2019
Data driven marketplace for matching research sites into clinical trials
Investor, Board Observer
2019
Tech-enabled mental health clinics to drive patient experience and outcomes
Octave provides mental health care that’s both accessible to people and sustainable for providers.
Raised $90,999,998.00 from Greycroft, Avidity Partners, Cigna Ventures, Felicis, Novo Holdings, Health Velocity Capital, Company Ventures and Obvious Ventures.
Investor
2018
Computational AAV discovery platform for gene therapy
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Raised $109,000,000.00 from Polaris Partners, KdT Ventures, Sahsen Ventures, Obvious Ventures, Andreessen Horowitz, CRV, Lux Capital, Casdin Capital and Google Ventures.
Investor, Board Director
2018
Deep learning development tool for explainability and data scoring
Education
Latest Articles
•
To RXRX and Beyond
Talks about Pharmaceutical, Venture Capital and Worldpositive
•
Promoting Meera Clark to Principal
Talks about Venture Capital, Startup and Entrepreneurship
•
Investing in Dexterity
Talks about Robotics, Automation and Entrepreneurship